Image pharmaphorum Editor News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials. News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it. News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion. Load more results
News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials.
News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.
News NICE says 'no' to Roche's Perjeta after breast cancer surger... NICE consulting on first draft decision
News Roche to buy rest of genetics firm Foundation Medicine Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.